scorecardresearch
Monday, September 22, 2025
TopicCovaxin

Topic: Covaxin

Australia recognises Bharat Biotech’s Covaxin for travellers as it reopens border

The recognition of Covaxin means Indians who have taken the vaccine will now be considered fully vaccinated on entry to Australia.

WHO-Covaxin-Modi govt is a triangle of confusion. No one knows what’s going on

The fact that it’s taken so long for Covaxin to get approval casts doubt on not only Bharat Biotech, but also the regulatory process in India.

WHO, UN experts at launch of book on Covaxin even as Bharat Biotech awaits emergency listing

'Going Viral: The Inside Story of Covaxin', written by ICMR DG Dr Balram Bhargava, was handed over to WHO and UN officials by the author during an event at UNAIDS office in Geneva.

Bharat Biotech’s partner Ocugen files request with US FDA for Covaxin trials

The proposed trial can be on people who either have not been vaccinated or who already received two doses of an mRNA vaccine at least six months earlier in the US.

Bharat Biotech’s Covaxin may get WHO recommendation ‘within next 24 hours’

WHO official Dr Margaret Harris said the technical advisory group that reviews all the data for a potential emergency use listing is studying Covaxin today (26 October).

India says given all Covaxin data to WHO, expect positive outcome at meeting next week

Long wait for Covaxin’s emergency-use listing has perplexed many. The issue was discussed at great length during Health Minister Mansukh Mandaviya’s meeting with WHO Director-General Tuesday.

WHO chief, Health Minister Mandaviya talk emergency use listing of Covaxin

During a call, WHO chief Tedros Adhanom Ghebreyesus and Health Minister Mansukh Mandaviya also discussed the resumption of supply of Covishield to COVAX facility.

‘Cannot cut corners’ — WHO says need more info from Bharat Biotech on Covaxin

Bharat Biotech had last month said it has submitted all data pertaining to Covaxin to the WHO for emergency use and is awaiting feedback from the global health watchdog.

WHO to consider emergency use listing of Covaxin on 26 October

Bharat Biotech, which has developed Covaxin, had submitted Expression of Interest to WHO on 19 April for its vaccine.

Scientific rationale, supply situation to guide decision on vaccinating kids, VK Paul says

Currently, three vaccines — Covishield, Covaxin and Sputnik V — being administered in the country are only for those above 18 years of age. All of them are two-dose vaccines.

On Camera

Festive seasons align with the rollout of GST 2.0. Citizens to get more money in hand

The new norm marks a decisive shift from the earlier complex system that created friction for households and small businesses alike.

Market regulator SEBI clears Adani Group of impropriety alleged by Hindenburg Research

SEBI probe concluded that purported loans and fund transfers were paid back in full and did not amount to deceptive market practices or unreported related party transactions.

30 civilians killed as Pakistan Air Force strikes Khyber Pakhtunkhwa village with China-made bombs

While Pakistani authorities have not clarified what intended target was, the incident adds to a troubling pattern of PAF strikes killing civilians, including women and children.

India doesn’t give walkovers to Pakistan in war. Here’s why it shouldn’t do it in cricket either

Many really smart people now share the position that playing cricket with Pakistan is politically, strategically and morally wrong. It is just a poor appreciation of competitive sport.